P4 medicine (Predictive, Preventive, Personalized, and Participatory) offers a comprehensive approach to personalized healthcare, emphasizing both the transition from disease to wellness and the importance of preventive care. In this perspective, we propose a…
Continue Reading
Sanofi and QuantHealth Team up to Advance AI-Powered Digital Twins and Clinical Trials Simulations to Accelerate Drug Development
QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture…
Image Credit: NVIDIA
What You Should Know:
– NVIDIA today unveiled a massive expansion of its healthcare AI initiatives, rolling out new open models as part of the NVIDIA Clara platform and announcing foundational partnerships with…
Continue Reading
Therapeutic toxicity, which can be life-threatening, presents a major challenge in treating patients with acute myeloid leukemia (AML). Medical digital twins, which are virtual representations of patient disease, have the potential to forecast disease…
Continue Reading
Health digital twin MOU signing (left to right) Mike Bishop, chief operating officer at Kidney Research UK,
Gareth Scargill, director at Nexus,
Amy Lochtie – West Yorkshire ICB Innovation Hub director, Laura Boyd, director of digital…
Generative artificial intelligence is revolutionizing digital twin development, enabling virtual patient representations that predict health trajectories, with large language models (LLMs) showcasing untapped clinical forecasting potential. We developed the Digital Twin—Generative Pretrained Transformer (DT-GPT),…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Smith, Co-Founder of Unlearn, to talk about how they use digital…
Continue Reading
Digital twins offer a promising approach to advancing healthcare by providing precise, noninvasive monitoring and early detection of diseases. In heart failure (HF), a leading cause of mortality worldwide, they can improve patient monitoring…
Continue Reading
Age is the most important risk factor for the majority human diseases, leading to the exploration of innovative approaches, including the development of predictors to estimate biological age (BA). These predictors offer promising insights…
Continue Reading
What You Should Know:
– Ryght AI, a leading AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies.
– The collaboration will bring advanced,…
Continue Reading
